|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 31/282 | |||
| A61K 31/513 | |||
| A61K 31/519 | |||
| C07K 16/28 | |||
| C07K 16/22 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2855528 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13729174.6 |
| Europos patento paraiškos padavimo data | 2013-05-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/043452 |
| Data | 2013-05-30 |
| (87) | Numeris | WO 2013/181452 |
| Data | 2013-12-05 |
| (30) | Numeris | Data | Šalis |
| 201261653861 P | 2012-05-31 | US |
| (72) |
MAECKER, Heather, US
IRVING, Bryan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, US |
| (54) | METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS |
| METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS |